Pure Global AI
NCT05891639Not yet recruiting

A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials

Investigating Factors Affecting Clinical Trial Participation Rates in Patients With Bipolar Disorder
Power Life Sciences Inc.ClinicalTrials.gov
Verified
Study focus
Disease/Condition
Bipolar Disorder
Study type
Observational
Sponsor & location
Primary sponsor
Power Life Sciences Inc.
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 01, 2026
Enrollment
500 participants
Primary outcome

Rate of bipolar disorder patients who decide to enroll in a clinical research.,Number of bipolar disorder study participants who remain in clinical research until completion.

Summary

Participation in clinical trials usually favors a particular demographic group. But there is
 limited research available to explain what study attributes affect the completion of these
 specific demographic groups.
 
 This study will investigate the safety and efficacy of bipolar disorder treatments. The focus
 will be on tracking the rates of completion and withdrawal among these individuals.
 
 It will also try to analyze data from the perspective of different demographic groups to
 check for recurring trends which might yield insights for the sake of future bipolar disorder
 study.

ICD-10 classifications
Bipolar affective disorderBipolar affective disorder, unspecifiedOther bipolar affective disordersBipolar affective disorder, currently in remissionBipolar affective disorder, current episode mixed
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05891639
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05891639 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Bipolar Disorder. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.